750 related articles for article (PubMed ID: 19039087)
1. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease.
Bamias G; Kaltsa G; Siakavellas SI; Gizis M; Margantinis G; Zampeli E; Vafiadis-Zoumboulis I; Michopoulos S; Daikos GL; Ladas SD
Dig Liver Dis; 2012 Jan; 44(1):30-6. PubMed ID: 21978578
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
4. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
Connor JP; Felder M
Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
[TBL] [Abstract][Full Text] [Related]
5. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
6. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.
Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD
Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196
[TBL] [Abstract][Full Text] [Related]
7. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
Sung HY; Wu HG; Ahn JH; Park WY
Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
[TBL] [Abstract][Full Text] [Related]
8. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
9. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
Zeissig S; Bojarski C; Buergel N; Mankertz J; Zeitz M; Fromm M; Schulzke JD
Gut; 2004 Sep; 53(9):1295-302. PubMed ID: 15306588
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia.
Kim S; Fotiadu A; Kotoula V
Clin Immunol; 2005 Jun; 115(3):286-94. PubMed ID: 15893696
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells.
Rosenstiel P; Fantini M; Bräutigam K; Kühbacher T; Waetzig GH; Seegert D; Schreiber S
Gastroenterology; 2003 Apr; 124(4):1001-9. PubMed ID: 12671897
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
[TBL] [Abstract][Full Text] [Related]
14. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
15. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
Li W; Zhang C; Chen C; Zhuang G
Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
[TBL] [Abstract][Full Text] [Related]
16. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.
Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH
Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521
[TBL] [Abstract][Full Text] [Related]
17. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
18. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
Maerten P; Geboes K; De Hertogh G; Shen C; Cadot P; Bullens DM; Van Assche G; Penninckx F; Rutgeerts P; Ceuppens JL
Clin Immunol; 2004 Sep; 112(3):239-46. PubMed ID: 15308117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]